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Abstract
Background: Community acquired pneumonia (CAP) is a major cause of morbidity and mortality. We recently
demonstrated that among young patients (<60 years old) with CAP, elevated red blood cell distribution width
(RDW) level on admission was associated with significant higher rates of mortality and severe morbidity. We aimed
to investigate the prognostic predictive value of RDW among CAP patients in general population of internal wards.
Methods: The cohort included patients of 18 years old or older who were diagnosed with CAP (defined as
pneumonia identified 48 hours or less from hospitalization) between January 1, 2005 and December 31, 2010.
Patients were retrospectively analyzed for risk factors for a primary endpoint of 90-day mortality. Secondary
endpoint was defined as complicated hospitalization (defined as at least one of the following: In- hospital mortality,
length of stay of at least 10 days or ICU admission). Binary logistic regression analysis was used for the calculation
of the odds ratios (OR) and p values in univariate and multivariate analysis to identify association between patient
characteristic, 90-day mortality and complicated hospitalization.
Results: The cohort included 3815 patients. In univariate analysis, patients with co-morbid conditions tended to
have a complicated course of CAP. In multivariate regression analysis, variables associated with an increased risk of
90-day mortality included age > 70 years, high Charlson comorbidity index (>2), Hb < 10 mg/dl, Na <130 meq/l,
blood urea nitrogen (BUN) >30 mg/dl, systolic blood pressure < 90 mmHg and elevated RDW >15%. Variables
associated with complicated hospitalization included high Charlson comorbidity index, BUN > 30 mg/dl,
hemoglobin < 10 g/dl, heart rate >124 bpm, systolic blood pressure < 90 mmHg and elevated RDW. Mortality rate
and complicated hospitalization were significantly higher among patients with increased RDW regardless of the
white blood cell count or hemoglobin levels.
Conclusions: Elevated RDW levels on admission are associated with significant higher rates of mortality and severe
morbidity in adult patients with CAP. RDW as a prognostic marker was unrelated with hemoglobin levels, WBC
count, age or Charlson score.
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Background
Community acquired pneumonia (CAP) is among the
leading causes of mortality and severe morbidity espe-
cially in elderly population. Despite the efficacy of mod-
ern antibiotic treatment, it still ranks as the sixth most
common cause of death [1-3]. Prognostic scores, like
the CURB65 score and the Pneumonia Patient Out-
comes Research Team score, were developed to estimate
the risk of adverse outcome in patients treated in emer-
gency rooms in an attempt to determine who is at risk
for an adverse outcome, and therefore should be hospi-
talized [4,5].
Red blood cell distribution width (RDW) is a laboratory
test used to evaluate variance in size or form of red blood
cell. It is an important marker for the differential diagnosis
of microcytic anemia. However, elevated RDW has been
recently shown to be associated with adverse prognosis in
several cardiac conditions [6-8], as well as acute stroke [9],
pulmonary thromboembolism [10], chronic kidney disease
[11], and septic shock [12].
The exact mechanisms causing elevated RDW in these
diverse conditions are unknown, however, it is assumed
to be related to inflammatory processes that might inter-
fere with the process of erythropoesis [13].
We have recently shown that among young patients
(60 years age and below), elevated RDW on admission,
either alone or in combination with abnormal white blood
cell count (WBC) count, was associated with adverse
outcome (defined as 90 days mortality and complicated
hospitalization) [14] . This prognostic value was unrelated
to hemoglobin levels. As young patients are an important,
but relatively small portion of patients seen in emergency
rooms with CAP, we aimed to investigate whether this
association is true also among the general population, es-
pecially in the elderly patients.
Methods
Patients aged 18 years old or older who were diagnosed
with CAP (defined as pneumonia identified within the first
48 hours of hospitalization) between 1 March, 2005 and
31 December, 2010 were retrospectively analysed to iden-
tify risk factors for complicated hospitalization and 90-day
mortality. The study was performed at Rambam Health
Care Campus which is a tertiary public government
hospital with 1000 admission beds in Northern Israel and
serves 1.5 million citizens. Data was collected from the
Prometheus, which is an integrated computer system for
handling patients’ medical records. The 90-day mortality
data was retrieved from the database of our hospital and
the ministry of health. We included only patients who had
radiologically confirmed new infiltrates.
Complicated hospitalization was defined as at least one
of the following parameters: hospitalization longer than
10 days, admission to ICU and in- hospital mortality.
Otherwise, the hospitalization was defined as uncompli-
cated. The Rambam Hospital Institutional Review Board
approved the study. The need for informed consent was
waived.
Exclusion criteria included age under 18 years, trans-
fer from another hospital, hospitalization during 30 days
prior to admission, hospital-acquired pneumonia (de-
fined as pneumonia which was diagnosed more than
48 hours after admission) or partial antibiotic treatment
before hospitalization.
The following data were retrieved from the electronic
medical records of the patients:
(1) Malignancies: solid tumours, hematologic malignan-
cies. (2) Pulmonary diseases: bronchial asthma, chronic
obstructive lung disease, interstitial lung disease, bronchi-
ectasis, permanent tracheostomy, lung malignancy, past
history of thoracic radiotherapy, previous episode of pneu-
monia, and previous or current active smoker. (3) Immune
suppression conditions: current chronic corticosteroid
treatment, current or recent chemotherapy treatment,
carrier of HIV, primary immune deficiency, history of
bone marrow transplantation. (4) Cardiovascular dis-
eases. (5) Chronic kidney disease including patients on
dialysis. (6) Diabetes mellitus. (7) Liver cirrhosis. (8) Prior
neurologic damage. (9) Chronic alcohol use. (10) Intra-
venous drug abuse. (11) Nursing house residents. The
Charlson comorbidity index (a score that predicts the ten-
year mortality for a patient who may have a range of
comorbid conditions, (a total of 22 conditions). Each con-
dition is assigned a score of 1, 2, 3, or 6, depending on the
risk of dying associated with each one. Scores are summed
to provide a total score to predict mortality) [15] was
calculated based upon this data. In addition, the vital
signs (heart rate, systolic blood pressure, body tem-
perature and oxygen saturation) of the patients were re-
corded on admission.
Laboratory variables on admission
Serum glucose, creatinine, sodium, hemoglobin, WBC,
RDW and blood urea nitrogen (BUN) were measured on
admission.
Hemoglobin levels, mean corpuscular volume and RDW
were measured on admission and prior to hospital dis-
charge, using the Advia 120 Hematology Analyzer (Sie-
mens Healthcare Diagnostics Deerfield, Illinois, USA).
Glucose, BUN and creatinine levels were measured
using the “Dimension” (Siemens Healthcare Diagnostics
Deerfield, Illinois, USA).
RDW is reported as coefficient of variation (in per-
cent) of red blood cell volume. The normal range for
RDW in our laboratory is 11.5 to 14.5%. The correctness
of this normal range was confirmed by analyzing RDW
data in 17,293 ambulatory subjects who attended the
Rambam Center for Preventive Medicine for a medical
Braun et al. BMC Infectious Diseases 2014, 14:129 Page 2 of 11
http://www.biomedcentral.com/1471-2334/14/129
examination and health counselling. In this group, mean
RDW was 13.1% (median 13.0%) with 95% confidence
interval (CI) of RDW of 12.0 to 14.4%.
Statistical analysis
Binary logistic regression analysis was used for the calcu-
lation of the odds ratios (OR) with 95% CI and P values
in univariate analysis to identify association between
patient characteristic and 90-day mortality and compli-
cated hospitalization. Multivariate forward stepwise logistic
regression was performed to assess the relation between
patient characteristics: co-morbidities, laboratory results,
and 90-day mortality or complicated hospitalizations.
Variables were selected as candidates for the multivari-
ate analysis on the basis of the level of significance of
the univariate association with 90-day mortality and com-
plicated hospitalization (P < 0.1). Notably, there was no
predilection in choosing RDW or any other variable in the
statistical model.
The area under curve (AUC) was used as a measure of
model of discrimination. The calibration of the predic-
tion equation was assessed by comparing the observed
and expected numbers of 90-day mortality or compli-
cated hospitalization. The calibration of the prediction
equation was assessed by comparing the observed and
expected numbers of 90-day mortality or complicated
hospitalization rate by decile of predicted risk. The
Hosmer-Lemeshow goodness-of-fit statistic was calcu-
lated. Comparing of patients characteristics from two
groups (complicated and uncomplicated) was done by
using chi-square test. Student’s t-test was used to compare
age between the two groups, whereas, length of stay was
compared using Mann–Whitney nonparametric test.
Two-tailed P values of 0.05 or less were considered as sta-
tistically significant. We calculated the Spearman’s rank
correlation coefficient to try to find out correlation bet-
ween variables that were found positive in the multivariate
analysis. All statistical analyses were performed using
SPSS (Statistics Products Solutions Services; Armonk,
New York, USA) 17.0 software for Windows; Redmond,
Washington, USA.
Results
The cohort included 3815 patients; 56.4% were males,
median age was 69.6 years, the in-hospital mortality rate
was 14.3% and the median length of stay was six days.
The median length of stay was 6 and 18.6 days in un-
complicated and complicated patients, respectively. In
patients who had a complicated course of pneumonia,
90-day mortality was 63.3% as compared with 11.6% in
uncomplicated patients (P < 0.03).
Univariate analysis of complicated hospitalizations and
90-day mortality
As shown in Table 1, 956 patients (28.1%) experienced
complicated hospitalization and 937 (24.6%) patients
died within 90 days of hospitalization; as expected, older
patients and those with co-morbid conditions (higher
Charlson score) tended to have a higher rate of both
end points.
Table 2 shows laboratory parameters checked for asso-
ciation with 90-day mortality and complicated admission.
Table 1 Baseline characteristics of the cohort with univariate analysis of risk factors for the detection of 90-day
mortality and complicated hospitalization
All patients Complicated admissions 90 days mortality
N (%) N (%) P value Odds ratio 95% CI N (%) P value Odds ratio 95% CI
3815 956 (28.1) 937 (24.6)
Male (%) 2153 (56) 564 546 (25.4) 1 -
Female (%) 1662 (44) 392 0.07 0.87 391 (23.5) 0.19 0.91 0.78 -1.05
Age (years) <50 592 (16) 98 (16.6) <0.001 1 1.16-2.19 38 (6.4) <0.001 1 -
50–59 395 (10) 95 (24.1) 0.004 1.59 1.05-1.89 61 (15.4) <0.001 2.663 1.737-4.082
60–69 573 (15) 125 (21.8) 0.023 1.41 1.3-2.18 101 (17.6) <0.001 3.12 2.107-4.62
70–79 971 (25) 243 (25) <0.001 1.68 1.8-2.99 245 (25.2) <0.001 4.92 3.435-7.046
80–89 1004 (26) 316 (31.5) <0.001 2.32 1.41-2.78 362 (36.1) <0.001 8.221 5.775-11.701
≥90 280 (7) 79 (28.2) <0.001 1.98 130 (46.4) <0.001 12.635 8.436-18.924
Charlson scoring 0 725 (19.0) 92 (12.7) 0.000 1 - 54 (7.4) .000 1 -
1 658 (17.2) 127 (19.3) 0.001 1.67 1.24-2.33 120 (18.2) .000 2.772 1.9-3.8
2 624 (16.4) 140 (22.4) 0.000 1.98 1.48-2.64 145 (23.2) .000 3.762 2.6-5.2
3–4 1002 (26.3) 311 (31.0) 0.000 3.09 2.39-4 310 (30.9) .000 5.567 4.1-7.5
5–7 606 (15.9) 214 (35.3) 0.000 3.75 2.85-4.94 216 (35.6) .000 6.882 4.9-9.5
8+ 200 (5.2) 81 (40.5) 0.000 4.65 3.25-6.65 92 (46.0) .000 10.585 7.1-15.6
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Multivariate analysis of 90-day mortality
All variables that were found to be associated (P < 0.1)
with 90-day mortality in the univariate analysis were in-
cluded in the initial multivariate prediction rule. Results
are presented in Table 3. In the model which does not
include RDW, variables that were associated with 90- day
mortality included: age > 70 years, charlson score >2,
systolic pressure < 90 mmHg, BUN > 30 mg/dl, Hb <
10 mg/dl, Na <130 meq/l. Whenever RDW was added
to the model, it was associated with 90- day mortality.
The model with included RDW improved AUCROC as
compared with a model without RDW from 0.773
(95% CI = 0.756-0.8) to 0.785 (95% CI = 0.769-0.8). The
Hosmer-Lemeshev goodness-of-fit statistic across decile
of risk was not statistically significant indicating little
departure and a perfect fit in both models.
Multivariate analysis of complicated hospitalizations
All variables that were associated (P < 0.1) with compli-
cated hospitalization were included in the initial multi-
variate prediction rule. Results of multivariate analysis
are presented in Table 4.
The variables that were associated with complicated
hospitalization included charlson score > 2, systolic blood
pressure <90 mmHg, heart rate >124 bpm, BUN >30 mg/dl
and Hb <10 mg/dl. Whenever RDW was added to the
Table 2 Laboratory and hemodynamic characteristics of the cohort with univariate analysis of risk factors for the
detection of 90-day mortality and complicated hospitalization
Complicated admissions 90 days mortality 95% CI
N N (%) P value Odds ratio 95% CI N (%) P value Odds ratio
Total 3815 956 (25.1) 937 (24.6)
BUN mg/dl ≤30 2762 537 (19.4) - 1 - 486 (17.6) - 1 -
>30 1053 419 (39.8) 0.000 2.74 2.34-3.20 451 (42.8) <0.001 3.51 3–4.10
Creatinine mg/dl ≤1.5 3010 645 (21.4) - 1 - 631 (21.0) - 1 -
>1.5 805 311 (38.6) 0.000 2.31 1.95-2.73 306 (38.0) <0.001 2.31 1.96-2.73
Hct ≥30 3238 749 (23.1) - 1 - 700 (21.6) - 1 -
<30 548 199 (36.3) 0.000 1.90 1.56-2.30 230 (42.0) <0.001 2.62 2.17-3.17
RDW % ≤15 2426 481 (19.8) - 1 - 408 (16.8) - 1 -
>15 1389 475 (34.2) 0.000 2.10 1.81-2.44 529 (38.1) <0.001 3.04 2.61-3.54
Glucose mg/dL ≤250 3491 843 (24.1) - 1 - 838 (24.0) - 1 -
>250 293 107 (36.5) 0.000 1.81 1.41-2.32 94 (32.1) 0.002 1.50 1.16-1.93
Hb g/dL ≥10 3189 726 (22.8) - 1 - 671 (21.0) - 1 -
<10 615 226 (36.7) 0.000 1.97 1.64-2.37 264 (42.9) <0.001 2.82 2.36-3.82
Na Meq/L <130 393 119 (30.3) 0.000 - - 111 (28.2) <0.001 - -
130 < <150 3301 782 (23.7) 0.004 0.72 0.57-0.90 753 (22.8) 0.016 0.75 0.59-.0.95
≥150 88 48 (54.5) 0.000 2.76 1.72-4.43 67 (76.1) <0.001 8.11 4.74-13.87
WBC×109/L <4- > 12 2023 576 (28.5) 0.000 1.49 1.28-1.73 574 (28.4) <0.001 1.56 1.34-1.81
4≤≤12 1781 376 (21.1) - 1 - 361 (20.3) - 1 -
PH ≥7.35 153 37 (24.2) - 1 - 43 (28.1) - 1 -
<7.35 2156 588 (27.3) 0.406 1.18 0.80-1.72 597 (27.7) 0.912 0.98 0.68-1.41
SBP (mmHg) ≥90 2858 657 (23.0) - 1 - 888 (23.9) - 1 -
<90 101 54 (53.5) 0.000 3.85 2.58-5.75 49 (48.5) 0.457 1.07 0.89-1.28
Temparature °C <40 2859 665 (23.3) - 1 - 932 (24.5) - 1 -
≥40 17 9 (52.2) 0.642 3.71 1.41-9.64 5 (29.4) 0.642 1.28 0.45-3.65
Pulse min−1 ≤124 2791 636 (22.8) - 1 - 888 (24.0) - 1 -
>124 141 60 (42.2) 0.005 2.51 1.78-3.55 49 (35.0) 0.005 1.67 1.17-2.38
SAT % 92-100 2041 431 (21.1) - 1 - 460 (23.0) - 1 -
<91 606 190 (31.4) <0.001 1.71 1.39-2.09 196 (32.0) <0.001 1.64 1.35-2.01
WBC White Blood Cells; RDW Red Cell Width Distribution.
Hct Hematocrit; Hb Hemoglobin; Na Sodium; SBP Systolic blood pressure; SAT Saturation.
BUN Blood Urea Nitrogen; SAT Oxygen Saturation.
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model, it was associated with complicated hospitalization.
A model with RDW improved AUCROC as compared with
a model without RDW from 0.744 (95% CI = 0.726-0.76)
to 0.757 (95% CI = 0.74-0.77). The Hosmer-Lemeshev
goodness-of-fit statistic across decile of risk was not statis-
tically significant indicating little departure and a perfect
fit in both models.
Spearman Rank Correlation coefficient was used to
find whether the parameters that were found to be sta-
tistically significant in multivariate analysis, were related
to each other. As shown in Table 5, there was no cor-
relation between elevated RDW and other parameters,
meaning that RDW represents an independent risk fac-
tor for 90-day mortality and complicated hospitalization.
The association of RDW, Charlson score and mortality
As depicted in Figure 1, complicated admission, in-hospital
mortality and 90-day mortality were directly related with
elevated RDW. Notably, higher RDW is correlated with
increased mortality, a linkage that was independent with
charlson score; even when this score was zero, increased
RDW predicted high mortality rates. This relationship was
maintained at any charlson score (Figure 2).
Relation between RDW, age and Charlson score
As shown in Figure 3, elevated RDW predicted increased
mortality rate in all age group. This association was stron-
ger in younger ages (less than 50), by which a 90- day
mortality of 20% was observed in patients with RDW >15,
as compared to 3% in patients with normal RDW on
admission. This relationship was maintained in all age
groups.
The association between the mortality rate, complicated
admission with RDW and the different white blood cell
groups
Complicated hospitalization and mortality rates were
significantly higher among patients with increased RDW
regardless of the WBC count (Figure 4); the complicated
hospitalization rate was 15.9% in patients with normal
RDW and WBC and 23.5% in patients with only abnor-
mal WBC count, as compared with 31.1% in patients
Table 3 Results of multivariate analysis of risk factors for 90-day mortality
Morality
Model without RDW Model with RDW
COEF P value Adjusted 95% CI for ODDS COEF P value Adjusted 95% CI for ODDS
ODDS Lower Upper ODDS Lower Upper
Charlson score 0 .000 .000
1 0.6 .003 1.7 1.2 2.5 .529 .005 1.7 1.2 2.5
2 0.7 .000 2.1 1.4 2.9 .626 .001 1.9 1.3 2.7
3-4 0.9 .000 2.5 1.8 3.5 .806 .000 2.2 1.6 3.2
5-7 1.1 .000 3.0 2.1 4.3 .971 .000 2.6 1.8 3.8
8+ 1.7 .000 5.7 3.7 8.7 1.550 .000 4.7 3.0 7.3
BUN (mg/dL) >30 0.5 .000 1.7 1.4 2.0 .518 .000 1.7 1.4 2.0
Hemoglobin (g/dL) <10 0.9 .000 2.4 2.0 2.9 .667 .000 1.9 1.6 2.4
WBC × 109/L <4- > 12 0.4 .000 1.4 1.2 1.7 .358 .000 1.4 1.2 1.7
Age Groups (years) <50 .000 .000
50-60 0.5 .018 1.7 1.1 2.7 .532 .022 1.7 1.1 2.7
60-70 0.5 .014 1.7 1.1 2.6 .498 .022 1.6 1.1 2.5
70-80 0.9 .000 1.7 1.1 3.6 .855 .000 4.1 2.8 6.1
80-90 1.4 .000 4.2 2.9 6.2 1.420 .000 4.1 2.8 6.1
≥90 1.9 .000 6.9 4.5 10.7 1.932 .000 6.9 4.4 10.7
Na (mMol/L) ≥150 1.8 .000 5.8 3.4 9.8 1.785 .000 6.0 3.5 10.1
SBP (mmHg) <90 0.9 .000 2.5 1.6 3.9 .803 .001 2.2 1.4 3.5
HR (min−1) >124 0.7 .001 1.9 1.3 2.9 .578 .006 1.8 1.2 2.7
O2 Saturation ≤91 0.3 .005 1.3 1.1 1.7 .286 .008 1.3 1.1 1.6
RDW >15 .739 .000 2.1 1.8 2.5
Constant −3.6 .000 0.0 −3.777 .000 0.0
WBC White Blood Cells; RDW Red Cell Width Distribution; Hct Hematocrit; Hb Hemoglobin; Na Sodium; SBP Systolic blood pressure; SAT Saturation; BUN Blood
Urea Nitrogen; HR Heart Rate; SAT Oxygen Saturation.
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with elevated RDW alone (P = 0.001) and 36.8% in pa-
tients with combined abnormal leukocyte count and in-
creased RDW (P < 0.001). The 90-day mortality was
higher in patients with elevated RDW regardless of the
WBC count; however, once again the combination of ab-
normal WBC and elevated RDW was significantly asso-
ciated with the highest mortality rates.
The association between the 90-day mortality rate and
complicated hospitalization with RDW and hemoglobin
groups
In order to rule out the possibility that RDW effect on
severe morbidity and mortality was related to anemia,
we compared complicated hospitalization in patients
with hemoglobin levels less than 110 g/L and higher
levels of Hb. As depicted in Figure 5, patients with
normal RDW had no difference in severe morbidity or
mortality regardless of Hb levels. On the other hand, el-
evated RDW was associated with a significant increase
in both complicated hospitalization and 90-day morta-
lity rates irrespective of Hb levels.
The relationship between adverse outcome, RDW and
elevated BUN
As shown in Figure 6, combination of elevated BUN and
RDW was associated with particularly high rates of pri-
mary and secondary endpoints. Notably, more than half
of the patients who had high levels of both BUN and
RDW on admission died within 90 days.
Discussion
This study shows that high level of RDW in admission is
an independent risk factor for adverse outcome, defined
as 90-days mortality and complicated hospitalization.
RDW, as a risk factor, was unrelated to other prognostic
factors at multivariate analysis.
We previously demonstrated that elevated RDW is as-
sociated with significantly higher rates of mortality and
severe morbidity among young patients hospitalized with
Table 4 Results of multivariate analysis of risk factors for complicated hospitalization
Complicated admissions
Model WO RDW Model WITH RDW
COEF P value Adjusted 95% for ODDS COEF P value Adjusted 95% for ODDS
ODDS Lower Upper ODDS Lower Upper
Charlson Score 0 .000 .000
1 0.4 .015 1.5 1.1 2.0 .356 .025 1.4 1.0 1.9
2 0.5 .003 1.6 1.2 2.2 .399 .013 1.5 1.1 2.0
3-4 0.8 .000 2.2 1.7 3.0 .723 .000 2.1 1.5 2.8
5-7 0.9 .000 2.6 1.9 3.5 .854 .000 2.3 1.7 3.2
8+ 1.2 .000 3.3 2.2 4.9 1.070 .000 2.9 2.0 4.3
BUN (mg/dL) >30 0.6 .000 1.8 1.5 2.1 .586 .000 1.8 1.5 2.1
Hemoglobin (g/dL) <10 0.5 .000 1.6 1.3 1.9 .328 .001 1.4 1.1 1.7
WBC × 109/L <4-2< 0.3 .000 1.4 1.2 1.6 .321 .000 1.4 1.2 1.6
Age groups (years) <50 - .026 - - - - .023 - - -
50-60 0.1 .386 1.2 0.8 1.6 .141 .414 1.2 0.8 1.6
60-70 −0.2 .313 0.8 0.6 1.2 -.190 .253 0.8 0.6 1.1
70-80 −0.1 .501 0.9 0.7 1.2 -.129 .398 0.9 0.7 1.2
80-89 0.2 .188 1.2 0.9 1.6 .174 .243 1.2 0.9 1.6
≥90 0.0 .962 1.0 0.7 1.5 -.013 .946 1.0 0.7 1.4
Na (mMol/L) ≥150 0.8 .001 2.2 1.4 3.4 .763 .001 2.1 1.4 3.4
SBP (mmHg) <90 1.0 .000 2.9 1.9 4.4 .983 .000 2.7 1.7 4.1
HR (min−1) >124 0.8 .000 2.1 1.5 3.1 .716 .000 2.0 1.4 3.0
O2 Saturation ≤91 0.2 .025 1.3 1.0 1.5 .220 .033 1.2 1.0 1.5
Temparature °C ≥40 1.4 .008 3.9 1.4 10.7 1.297 .012 3.7 1. 10.0
RDW >15 .413 .000 1.5 1.3 1.8
Constant −2.3 .000 0.1 −2.371 .000 0.1
WBC White Blood Cells; RDW Red Cell Width Distribution; Hb Hemoglobin; Na Sodium; SBP Systolic blood pressure; SAT Saturation; BUN Blood Urea Nitrogen;
HR Heart Rate; SAT Oxygen Saturation.
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Table 5 Spearman rank correlation coefficient parameters
Total RDW< 13.2 RDW 13.2-15 RDW> 15 Spearman coefficient
N N (%) N (%) N (%) P
Hemoglobin ≥10 3189 456 (17) 1772 (55.6) 961 (30.1) 0.29 <0.001
<10 615 14.3 (2.8) 176 (28.6) 422 (68.6)
WBC <4 133 13 (9.8) 32 (24.1) 88 (66.2) −0.05 0.001
≥12 1781 239 (13.4) 920 (51.7) 622 (34.9)
4≤ ≤12 1890 221 (11.7) 996 (52.7) 673 (35.6)
Creatinine <1.5 3010 443 (14.7) 1563 (51.9) 1004 (33.4) 0.16 <0.001
1.5-2 378 18 (4.8) 192 (50.8) 168 (44.4)
>2 409 10 (2.4) 191 (46.7) 208 (50.9)
Na <130 393 57 (14.5) 183 (46.6) 153 (38.9) 0.01 0.5
130 < <150 3301 412 (12.5) 1710 (51.8) 1179 (35.7)
≥150 88 4 (4.5) 43 (48.9) 41 (46.6)
BUN ≤30 2762 420 (15.2) 1452 (52.6) 890 (32.2) 0.17 <0.001
>30 1019 52 (5.1) 483 (47.4) 484 (47.5)
HCT ≥30 3238 456 (14.1) 1760 (54.4) 1022 (31.6) 0.24 <0.001
<30 548 17 (3.1) 180 (32.8) 351 (64.1)
O2 SAT% 92-100 2041 270 (13.2) 1036 (50.8) 735 (36.0)
≤91 606 54 (8.9) 297 (49.0) 255 (42.1)
Age <50 592 174 (29.4) 297 (50.2) 121 (20.4) 0.18 <0.001
50–59 395 70 (17.7) 204 (51.6) 121 (30.6)
60–69 572 67 (11.7) 284 (49.7) 221 (38.6)
70–79 972 81 (8.3) 485 (49.9) 406 (41.8)
80–89 1004 63 (6.3) 533 (53.1) 408 (40.6)
≥90 280 19 (6.8) 149 (53.2) 112 (40.0)
WBC White Blood Cells; Hct Hematocrit; Hb Hemoglobin; Na Sodium; SAT Saturation; BUN Blood Urea Nitrogen; SAT Oxygen Saturation.
Figure 1 Complicated admission, in-hospital mortality and 90-day mortality association with elevated RDW.
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CAP [14]. However, the majority of the patients admit-
ted with CAP are elderly patients, in whom the rates of
death and complications are much higher [16]. Despite
the progress in antibiotic treatment and handling of crit-
ically ill patients in the modern era, the rates of death in
this group of patients are still high, making CAP among
the leading causes of death in patients in advanced ages.
The high burden of CAP and limited number of beds in
ICU’s in Israel and many European countries denotes
that physicians in the emergency departments need sim-
ple and inexpensive tools to decide in a short time frame
which patients need hospitalization and particularly who
should be a candidate for admission to ICU’s.
Among many risk factors that were examined in this
study for adverse outcome in patients with CAP, two
stand out: RDW and BUN [17,18]. At ROC models, both
parameters were significantly associated with both com-
plicated hospitalization and 90-day mortality compared
with other important factors such as elevated glucose,
hypernatremia, high levels of creatinine and abnormal
WBC counts- all widely considered as adverse factors in
CAP and frequently incorporated in various scores (e.g.
PORT score) used in flow charts of decision making in
emergency departments. Combination of high levels of
both RDW and BUN was associated with particularly
high levels of mortality; more than half of the patients
Figure 2 The relationship between RDW and charlson score. (CI- Charlson Index).
Figure 3 The relation between RDW and age.
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admitted with high levels of BUN and elevated RDW
died within 90 days. Indeed, Hunziker et al. [19] recently
suggested that RDW significantly improves risk stratifi-
cation for simplified acute physiological score to predict
short and long term mortality rates in a large and unse-
lected population of ICU patients.
Elevated RDW has been shown to be an important risk
factor in various cardiovascular conditions, such as acute
decompensated heart failure [20], acute coronary syn-
dromes [6-8] and stroke [9]. Recently, RDW emerged as
an independent risk factor in inflammatory and infec-
tious conditions: Ku et al. demonstrated recently that
RDW is an independent predictor of mortality among
patients with gram-negative bacteremia [21]. Acute and
chronic hepatitis B [22] and activity of inflammatory
bowel disease [23] have also been recently associated
with elevated RDW.
It should be noted that although this cohort included
elderly patients in which high rates of anemia of iron de-
ficiency or chronic disease is expected, high rates of ad-
verse outcome were shown in all age and charlson score
groups. While this trend is especially notable in younger
patients, it is maintained in octogenarian and nanogen-
erian patients.
In concordance with our study, recently Lee et al.
demonstrated in 744 patients that elevated RDW on ad-
mission was associated with increased 30-day mortality,
length of hospital stay, and use of vasopressors in hospital-
ized patients with CAP. The inclusion of RDW improved
the prognostic performance of the PSI and CURB-65 [24].
Figure 4 The association between mortality rate, complicated admission with RDW and the different white blood cell groups.
Figure 5 The association between 90-day mortality rate and complicated hospitalization with RDW and different hemoglobin levels.
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Notably, our study included more patients (3815 patients)
and showed both a short and long term association
with RDW on adult pneumonia outcome. Moreover, we
showed that the effect of elevated RDW is maintained in a
larger spectrum of age and a variety of co-morbidities.
The mechanism underlying the association between
high levels of RDW and adverse outcome in patients
hospitalized with pneumonia is unknown. Our data sug-
gests that RDW might be regarded as a valuable and
sensitive marker for a high level of inflammatory activity
in adult patients with CAP, and it is independent of
hemoglobin levels. A mechanism that could be involved
in such a process is the release of cytokines in response
to inflammatory stress. These cytokines might block the
activity of erythropoietin, inhibit erythrocyte maturation
and cause production of ineffective red blood cell and
elevated RDW [13]. Lippi et al. found a correlation be-
tween high RDW and elevated indexes of inflammation,
such as elevated erythrocyte sedimentation rate (ESR)
and C-reactive protein (CRP). This correlation was inde-
pendent of concomitant diseases, and was demonstrated
even when anemic patients were excluded from the statis-
tical analysis [25]. This might represent a culmination of
multiple pathophysiologic processes occurring in acute in-
flammatory and infectious states. Thus, elevated RDW on
admission may indicate a severe inflammatory process,
which could be an early sign of adverse prognosis in pa-
tients hospitalized with CAP.
The major limitation of this study is that it is retro-
spective. It should be validated in a prospective study,
preferably with inclusion of other inflammatory markers,
such as CRP, Procalcitonin and IL-6. Conceivably, RDW
should be evaluated for incorporation in the commonly
used risk assessment scores. The very old population
(>80), included in this study, had high rates of anemia
and other pro- inflammatory conditions which might
have led to overestimation of RDW as a prognostic fac-
tor in this group of patients. Moreover, there were not
enough patients in whom iron levels, LDH and other pa-
rameters of hemolysis were checked to reach statistical
power to include them in the univariate analysis.
Conclusions
Elevated RDW levels on admission are associated with sig-
nificant higher rates of mortality and severe morbidity in
adult patients with CAP. RDW as a prognostic marker
was unrelated with hemoglobin levels or other risk factors
for adverse outcome in patients with CAP.
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